Harbor - UCLA Psilocybin & Cancer

This is the first psychedelic treatment with terminally ill patients since the early 1970's. The study examines the use of psilocybin in a controlled setting to reduce the psychospiritual anxiety, depression, and physical pain of terminal cancer patients. As a society we spend a great deal of attention treating cancer, but very little treating the human being who is dying of cancer. This study treats the whole human being. It aims to help the patient move towards a 'good' death, and help the patient's family deal well with the dying process of their loved one. If we can learn to work more skillfully with dying, we will also learn to take better care of life.

The study of 12 subjects has been completed and published: Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. (2011) Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer. Arch Gen Psychiatry. 2011;68(1):71-78. doi:10.1001/archgenpsychiatry.2010.116. Dr. Charles Grob, M.D., a Heffter founder, directed the project.